Our results indicate that alterations of SGCG, PROS1 and ITGB1 genes appeared prevalently in grade III astrocytomas and resulted in shorter survival of patients, implying more aggressive nature of tumors with this genetic signature. This evidence concerns the gene PROS1 and astrocytoma (excluding glioblastoma).